Antibiotics?
Asking for Preferences
Asking for Preferences
Reading File
Finding Sources
Searching PubMed
ceftriaxone clinical use pharmacology
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have comprehensive information from multiple authoritative textbooks. Here is the full profile of ceftriaxone:
Ceftriaxone
Class: 3rd-generation cephalosporin (beta-lactam antibiotic)
Mechanism of Action
Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), blocking transpeptidation (cross-linking of peptidoglycan chains). This leads to cell lysis and death. It is bactericidal.
Antimicrobial Spectrum
Ceftriaxone is a broad-spectrum antibiotic with excellent coverage of:
- Gram-positives: Streptococcus pneumoniae (including most penicillin-resistant strains), Streptococcus pyogenes, Streptococcus viridans
- Gram-negatives: Neisseria meningitidis, N. gonorrhoeae, Haemophilus influenzae, Enterobacteriaceae (E. coli, Klebsiella, Proteus), most Enterobacterales
- Notable gaps: No reliable MRSA coverage, no activity against Pseudomonas aeruginosa (unlike cefepime), poor anaerobe coverage, no Enterococcus coverage
Key Clinical Indications
| Condition | Regimen |
|---|---|
| Bacterial meningitis | 100 mg/kg/day IV ÷ Q12h (children); 2 g IV Q12h (adults) |
| Community-acquired pneumonia (inpatient) | 1-2 g IV once daily + macrolide |
| Gonorrhea (uncomplicated) | 500 mg IM x1 (<150 kg); 1 g IM x1 (≥150 kg) |
| Pelvic inflammatory disease (severe) | 1 g IV once daily + doxycycline + metronidazole x14 days |
| Lyme disease (disseminated/neurologic) | 2 g IV once daily |
| Acute otitis media (refractory) | 50 mg/kg IM x1 (max 1 g); repeat x3 for relapse |
| Endocarditis prophylaxis | 1 g IV/IM 30-60 min before procedure (adults) |
| Septicemia / intra-abdominal infections | 1-2 g IV Q12-24h |
- Goldman-Cecil Medicine notes ceftriaxone + cefotaxime as first-line for pneumococcal meningitis (penicillin MIC ≥2 µg/mL: add vancomycin)
- Harrison's 22E confirms ceftriaxone as first-line for H. influenzae meningitis at 75-100 mg/kg/day in children
Dosing
Adults: 1-2 g IV/IM every 12-24 hours; max 2 g per dose, 4 g per day
Children (>1 month):
- Mild/moderate infections: 50-75 mg/kg/day ÷ Q12-24h (max 2 g/day)
- Severe infections/meningitis: 100 mg/kg/day ÷ Q12h (max 4 g/day)
Neonates (gonococcal prophylaxis): 25-50 mg/kg IM/IV x1; max 250 mg
Route: IV or IM. For IM, dilute with sterile water or 1% lidocaine to 250-350 mg/mL.
Renal dosing: Unlike most beta-lactams, ceftriaxone has significant biliary excretion (35-45%), so dose adjustment is generally NOT required in renal impairment alone.
Key Pharmacokinetic Features
- Half-life: ~6-9 hours - allows once-daily dosing (unique among cephalosporins)
- Protein binding: Very high (~85-95%)
- Elimination: Both renal and biliary (35-45% biliary - distinctive)
- CNS penetration: Good with inflamed meninges
Adverse Effects & Side Effects
- Rash, injection site pain
- Diarrhea (including C. difficile risk)
- Transient elevation of liver enzymes
- Reversible cholelithiasis / biliary sludging / jaundice (due to biliary excretion; may mimic gallstones on imaging)
- Reversible neurologic reactions in post-marketing reports (encephalopathy, seizures, myoclonus) - especially in renal failure
- False-positive Clinitest/Benedict's urinary glucose tests (use enzymatic tests like Clinistix instead)
- False interference with Jaffe creatinine assay
Contraindications & Cautions
| Situation | Issue |
|---|---|
| Neonates + IV calcium | FATAL ceftriaxone-calcium precipitates in lungs/kidneys - contraindicated in <28 days old if receiving IV calcium (including TPN) |
| Hyperbilirubinemic neonates | Ceftriaxone displaces bilirubin from albumin - contraindicated |
| Penicillin allergy | Cross-reactivity is low (~1-2%), but use with caution |
| Gallbladder/biliary/pancreatic disease | Use with caution |
| Simultaneous IV calcium (any age) | Never co-administer via Y-site (flush lines thoroughly before/after) |
Critical warning: Several fatal cases of ceftriaxone-calcium precipitation in premature and full-term neonates have been reported. Never mix or co-administer with calcium-containing IV products in neonates. - Harriet Lane Handbook, 23rd ed.
Drug Interactions & Lab Interference
- Synergistic with ampicillin for E. faecalis endocarditis (ampicillin + ceftriaxone combination inhibits the full complement of PBPs)
- Avoid simultaneous IV calcium-containing fluids at any age via Y-site
- Not combined with vancomycin or gentamicin for enterococcal IE (not bactericidal)
Pregnancy & Special Populations
Category B (generally considered safe); excreted in breast milk in low concentrations. Use caution in neonates due to hyperbilirubinemia risk.
Sources: Harriet Lane Handbook 23rd ed.; Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine; Rosen's Emergency Medicine; Red Book 2021 (AAP)
This is a shared conversation. Sign in to Orris to start your own chat.